Sources sought
2 PAM Autoinjectors
2-PAM-BARDA
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
May 14, 2025 at 4:00 PM EDT
Closed 491 days ago. Posted April 22, 2025. Scheduled to archive May 29, 2025.
Description
As published on SAM.gov.
BARDA seeks pertinent marketplace data on availabilities and capabilities for procuring, stockpiling, and investing in the late-stage development of Pralidoxime (2-pyridine aldoxime methyl chloride; 2-PAM) autoinjectors for intramuscular injection. BARDA seeks information on availability, capabilities, and other pertinent marketplace data to support late-stage activities required for Food and Drug Administration (FDA) approval of 2-PAM (600 mg) autoinjectors.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 22, 2025
Sources sought
Due May 14, 2025 at 4:00 PM EDT. SAM.gov, notice 028451b7e45b4bcab1eb112d1934f2f5
Points of contact
- Kevin Dean, Contracting Specialistkevin.dean1@hhs.gov2029895371
- Erin Greninger, Contracting Officererin.greninger@hhs.gov7712107767
Also open from this buyer
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseSolicitationNAICS 541714Washington, DC75A50126R00001_RFP_NPIVS_27Closes in 64 daysNov 20
- BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)SolicitationNAICS 541714DRIVeEZBAA22100SOL00003Closes in 396 daysOct 18, 2027